摘要 |
FIELD: medicine, pharmaceutics. ^ SUBSTANCE: invention refers to medicine, namely endocrinology, cardiology and can be used for treating dislipidemia. That is ensured by introducing a pharmaceutical composition containing a thiazolidinedione analogue of formula ^ EFFECT: introducing the compound of formula 1 having decreased binding and activation of PPAR-gamma nuclear transcription factor, enables effective treatment of dislipidemia with no adverse side effects typical for PPAR-gamma agonists. ^ 2 dwg, 5 tbl, 5 ex |